New England Cell Therapeutics, Inc.
Renny Clark currently serves as the Executive Vice President and Chief Financial Officer at Spryte Medical and GENTUITY, LLC, as well as New England Cell Therapeutics, Inc. Previously, Renny held the position of Chief Financial Officer at CardioFocus, where responsibilities included raising capital and managing financial operations. Renny's extensive experience in finance is complemented by roles at LightLab Imaging, Inc., Boston Scientific, Hewlett-Packard Company, and The Chase Manhattan Bank, demonstrating proficiency in financial reporting, planning, and analysis across various sectors, particularly in medical devices and healthcare. Renny's academic credentials include an MBA in Finance and Marketing from The Wharton School, a BA in Political Studies from Pitzer College, and a Master of Science in Accounting from the University of Massachusetts Lowell.
This person is not in any teams
This person is not in any offices